Results 81 to 90 of about 4,045,135 (314)

Intrapatient tumour heterogeneity and clonal evolution in an autopsy study of metastatic salivary gland cancer

open access: yesMolecular Oncology, EarlyView.
Tumour heterogeneity and clonal evolution of metastatic salivary gland cancer were evaluated in two patients with adenoid carcinoma and one patient with myoepithelial carcinoma. Radiology‐guided autopsy enabled multi‐region sampling (total samples n = 149), followed by whole‐genome sequencing and phylogenetic reconstruction (17 tumour samples, 4–7 per ...
Gerben Lassche   +10 more
wiley   +1 more source

Somatostatin receptor 4 (SSTR4) is a tumor suppressor in cutaneous and head & neck squamous cell carcinomas

open access: yesMolecular Oncology, EarlyView.
This study identifies somatostatin receptor 4 (Sstr4) as a critical tumor suppressor against skin and head/neck cancers (HNSCC, cSCC, and BCC). The loss of Sstr4 removes a check on cell growth, causing hyperactivation of the MAPK‐ERK signaling pathway (↑).
Ali Taqvi   +6 more
wiley   +1 more source

KM plot of 2 molecular subtypes of TSCC.

open access: yes, 2019
KM plot of 2 molecular subtypes of TSCC.
Zaiye Li (6752435)   +2 more
core   +1 more source

Profiling neoadjuvant therapy response in rectal cancer using meta‐analysis of publicly available transcriptomic RNA‐seq datasets

open access: yesMolecular Oncology, EarlyView.
This study integrates publicly available transcriptomic datasets to identify molecular signatures associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. By analyzing a combination of multiple cohorts with bioinformatics approaches, we reveal biological pathways and immune‐related features that may improve ...
Aleksandra Stanojevic   +10 more
wiley   +1 more source

Heatmap of DEmRNAs between 2 molecular subtypes of TSCC.

open access: yes, 2019
Heatmap of DEmRNAs between 2 molecular subtypes of TSCC.
Zaiye Li (6752435)   +2 more
core   +1 more source

A prognosis-related molecular subtype for early-stage non-small lung cell carcinoma by multi-omics integration analysis

open access: yesBMC Cancer, 2021
Background Early-stage non-small cell lung carcinoma (NSCLC) accounts for more than 80% of lung cancer, which is a kind of cancer with high heterogeneity, so the genetic heterogeneity and molecular subtype should be explored.
Kai Yang, Ying Wu
doaj   +1 more source

The VHL tumor suppressor at the crossroad of protein folding, aggregation, and cancer

open access: yesMolecular Oncology, EarlyView.
Mutations, environmental stress, and chaperone dysfunction can destabilize pVHL, promoting its conversion from the native folded state into amyloid‐like assemblies. This transition may contribute to protein storage, cell dormancy, survival, and drug resistance.
Lara Abad   +2 more
wiley   +1 more source

MOLECULAR BIOLOGY AND PHARMACOLOGY OF HISTAMINE RECEPTOR SUBTYPES [PDF]

open access: yesClinical Neuropharmacology, 1992
Author(s): Ruat, M; Traiffort, E; Leurs, R; Arrang, JM; Kouyoumdjian, G; Tardivel-Lacombe, J; Piomelli, D; Diaz, G; Schwartz ...
Ruat, M   +8 more
openaire   +5 more sources

Gut microbiota alterations in patients with non‐small‐cell lung cancer undergoing chemoradiotherapy

open access: yesMolecular Oncology, EarlyView.
We investigated the impact of concurrent chemoradiotherapy (CRT) on the gut microbiota in patients with locally advanced non‐small‐cell lung cancer. Overall gut microbiota composition remained largely stable throughout CRT while antibiotic exposure may influence microbial diversity.
Hanne Marte Nymoen   +19 more
wiley   +1 more source

Clinical prognosis of 4 GBM molecular subtypes.

open access: yes, 2014
173 TCGA core GBMs' molecular subtypes were determined by TCGA group (A) or the NTP method (B). (A–B) Kaplan Meier curves display overall survivals of the subtypes.
Yeup Yoon (607298)   +15 more
core   +1 more source

Home - About - Disclaimer - Privacy